Off Market Opportunities

The Company is a U.S.-based life sciences innovator focused on developing clinically validated, IP-protected therapies targeting Chronic Kidney Disease (CKD) in companion animal populations.
The Company's lead compound — a proprietary amino acid/peptide complex — has demonstrated renoprotective properties across multiple peer-reviewed studies and holds granted patents in the United States and Europe.
The Company is using an asset-light manufacturing model through production in cGMP certified 3rd party facilities. Consistent double-digit topline growth, healthy profitability, and a robust innovation pipeline focused on expanding into adjacent, underserved pet categories position the business for sustained long-term growth.